185
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Comparative modeling and structure based drug repurposing of PAX2 transcription factor for targeting acquired chemoresistance in pancreatic ductal adenocarcinoma

, , &
Pages 2071-2078 | Received 17 Feb 2020, Accepted 10 Mar 2020, Published online: 25 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wan-Atirah Azemin, Nadiawati Alias, Abdul Manaf Ali & Mohd Shahir Shamsir. (2023) In silico analysis prediction of HepTH1-5 as a potential therapeutic agent by targeting tumour suppressor protein networks. Journal of Biomolecular Structure and Dynamics 41:4, pages 1141-1167.
Read now

Articles from other publishers (3)

Carmen Muntean, Camelia Chirtes, Balazs Baczoni & Claudia Banescu. (2023) PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review. International Journal of Molecular Sciences 24:16, pages 12737.
Crossref
Md. Hafiz Uddin, Md. Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel El-Rayes & Asfar S. Azmi. (2022) Aberrant transcription factors in the cancers of the pancreas. Seminars in Cancer Biology 86, pages 28-45.
Crossref
Krishnaprasad Baby, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak & Yogendra Nayak. (2020) Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19. F1000Research 9, pages 1166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.